XOMA Co. (NASDAQ:XOMAO – Get Free Report) declared a quarterly dividend on Thursday, June 11th. Investors of record on Thursday, July 2nd will be paid a dividend of 0.5234 per share on Tuesday, July 14th. This represents a c) dividend on an annualized basis and a yield of 8.2%. The ex-dividend date is Thursday, July 2nd.
XOMA Stock Performance
Shares of XOMAO opened at $25.45 on Tuesday. XOMA has a one year low of $24.86 and a one year high of $26.40. The firm has a 50 day simple moving average of $25.35 and a two-hundred day simple moving average of $25.42.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early?stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Further Reading
- Five stocks we like better than XOMA
- SpaceX Achieves Escape Velocity With Nasdaq Fast-Track
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
